DYNC1H1
Overview
DYNC1H1 is a gene that encodes the cytoplasmic dynein 1 heavy chain 1 protein, which is a crucial component of the dynein motor complex. This complex is responsible for retrograde intracellular transport along microtubules, playing a vital role in various cellular processes, including mitosis, organelle transport, and cell signaling.
Structure
The DYNC1H1 gene is located on chromosome 14 in humans and spans approximately 1.5 million base pairs. The protein product of DYNC1H1 is a large polypeptide with a molecular weight of approximately 532 kDa. It contains several functional domains, including the motor domain responsible for ATP hydrolysis and microtubule binding, and the tail domain, which interacts with cargo and other dynein subunits.
Function
DYNC1H1 is a key component of the cytoplasmic dynein complex, which is involved in the transport of various cellular cargos, such as organelles, protein complexes, and mRNA, towards the minus end of microtubules. This retrograde transport is essential for maintaining cellular organization and function. Dynein also plays a critical role in mitosis, where it helps in the positioning of the mitotic spindle and the segregation of chromosomes.
Clinical Significance
Mutations in the DYNC1H1 gene have been associated with several neurological disorders, including Charcot-Marie-Tooth disease, spinal muscular atrophy, and intellectual disability. These mutations can lead to defects in neuronal transport, resulting in neurodegeneration and other clinical manifestations.
Research and Developments
Recent studies have focused on understanding the precise mechanisms by which DYNC1H1 mutations lead to disease, as well as exploring potential therapeutic strategies to correct or compensate for these defects. Advances in CRISPR-Cas9 technology and other gene-editing tools hold promise for developing targeted treatments for conditions associated with DYNC1H1 mutations.
Also see
| Genetics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
* Category
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian